Mytos has entered into a manufacturing collaboration with Aspen Neuroscience Inc. to automate the manufacturing of autologous ...

Mytos' automated cell culture technology will power manufacturing of dopaminergic neuronal precursor cells for Aspen's investigational cell therapy ANPD001 in Parkinson's disease Mytos, an innovative ...

The global Cell Therapy Technologies market, valued at US$3.89 billion in 2023, is forecasted to grow at a robust CAGR of ...

The Life Science business of Merck KGaA, Darmstadt, Germany, has acquired HUB Organoids B.V. (HUB), as announced by ...

In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell ...

Advanced RNA sequencing technology helped determine which parental copy of a gene was active in each ... leading to a “non-disease” state. “At least in cell culture in the lab we can do it, so ...

Dec. 18, 2024 — Scientists have generated human stem cell models which contain notochord -- a tissue in the developing embryo that acts like a navigation system, directing cells where to build ...

Researchers from the Organoid group at the Hubrecht Institute have developed a new way to grow organoids. Organoids are tiny ...

Large language models unleashed the power of AI. Now it’s time for more efficient AIs to take over. After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and ...

Under the partnership, the companies say they will offer clients more relevant and functional assays for drug development.

Professor Michel Sadelain and Professor Sumio Iijima, among other eminent figures, were selected to win the 47th session of ...

The newly approved methastatic Renal Cell Cancer (mRCC) Phase 1/2a trial began in Q4 2024, and Genenta expects to treat six patients by the end of the first half of 2025, while continuing progress ...